The TGA has published a permission under section 42DK of the Therapeutic Goods Act 1989 that specifies what must and must not be said when advertising COVID-19 rapid antigen tests to consumers (which includes businesses and organisations).
Guidance for advertising COVID-19 rapid antigen tests
We have published guidance which explains how parties can lawfully advertise COVID-19 rapid antigen point-of-care tests for use by or under the supervision of a relevant health practitioner, or COVID-19 rapid antigen self-tests for supply to consumers for home use testing, and meet the requirements set out in the advertising permission.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.